Submission for OMB Review; 30-Day Comment Request: Request for Human Embryonic Stem Cell Line To Be Approved for Use in NIH Funded Research (Office of the Director)

Citation84 FR 35401
Record Number2019-15659
Published date23 July 2019
SectionNotices
CourtNational Institutes Of Health
Federal Register, Volume 84 Issue 141 (Tuesday, July 23, 2019)
[Federal Register Volume 84, Number 141 (Tuesday, July 23, 2019)]
                [Notices]
                [Pages 35401-35402]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2019-15659]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                National Institutes of Health
                Submission for OMB Review; 30-Day Comment Request: Request for
                Human Embryonic Stem Cell Line To Be Approved for Use in NIH Funded
                Research (Office of the Director)
                AGENCY: National Institutes of Health, HHS.
                ACTION: Notice.
                -----------------------------------------------------------------------
                SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
                National Institutes of Health (NIH) has submitted to the Office of
                Management and Budget (OMB) a request for review and approval of the
                information collection listed below.
                DATES: Comments regarding this information collection are best assured
                of having their full effect if received within 30-days of the date of
                this publication.
                ADDRESSES: Written comments and/or suggestions regarding the item(s)
                contained in this notice, especially regarding the estimated public
                burden and associated response time, should be directed to the: Office
                of Management and Budget, Office of Regulatory Affairs,
                [email protected] or by fax to 202-395-6974, Attention: Desk
                Officer for NIH.
                FOR FURTHER INFORMATION CONTACT: To request more information on the
                proposed project or to obtain a copy of the data collection plans and
                instruments, contact: Dr. Ellen Gadbois, Office of the Director, NIH,
                Building 1, Room 218, MSC 0166, 9000 Rockville Pike, Bethesda, MD
                20892, or call non-toll-free number (301) 496-9838 or email your
                request, including your address to: [email protected].
                SUPPLEMENTARY INFORMATION: This proposed information collection was
                previously published in the Federal Register on May 16, 2019, page
                22153 (84 FR 22153) and allowed 60 days for public comment. No public
                comments were received. The purpose of this notice is to allow an
                additional 30 days for public comment. The NIH Office of the Director
                may not conduct or sponsor, and the respondent is not required to
                respond to, an information collection that has been extended, revised,
                or implemented on or after October 1, 1995, unless it displays a
                currently valid OMB control number.
                 In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
                Act of 1995, the National Institutes of Health (NIH) has submitted to
                the Office of Management and Budget (OMB) a request for review and
                approval of the information collection listed below.
                 Proposed Collection: Request for Human Embryonic Stem Cell Line to
                be approved for Use in NIH Funded Research. OMB No. 0925-0601--
                Extension--Expiration Date 07/31/2019--Office of the Director, National
                Institutes of Health (NIH).
                 Need and Use of Information Collection: The form is used by
                applicants to request that human embryonic stem cell lines be approved
                for use in NIH funded research. Applicants may submit applications at
                any time.
                 OMB approval is requested for 3 years. There are no costs to
                respondents other than their time. The total estimated annualized
                burden hours are 255 per respondent.
                 Estimated Annualized Burden Hours
                ----------------------------------------------------------------------------------------------------------------
                 Number of Average time
                 Type of respondent Number of responses per per response Total annual
                 respondents respondent (in hours) burden hours
                ----------------------------------------------------------------------------------------------------------------
                NIH grantees and others with hESC lines......... 5 3 17 255
                 ---------------------------------------------------------------
                 Total....................................... .............. 15 .............. 255
                ----------------------------------------------------------------------------------------------------------------
                [[Page 35402]]
                 Dated: July 17, 2019.
                Lawrence A. Tabak,
                Principal Deputy Director, National Institutes of Health.
                [FR Doc. 2019-15659 Filed 7-22-19; 8:45 am]
                BILLING CODE 4140-01-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT